Insider · CIK 0001423035
Thomas X Geisel
Files at DCOM (Dime Community Bancshares, Inc. /NY/). First filing -, latest -.
In brief
Thomas X Geisel files SEC Form 4 as officer at DCOM (Dime Community Bancshares, Inc. /NY/). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Thomas X Geisel has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | DCOM Dime Community Bancshares, Inc. /NY/ | AGrant or award Common Stock | +4,779 | $0.00 | $0 | 8,326 | Apr 6, 2026 |
| Mar 31, 2026 | DCOM Dime Community Bancshares, Inc. /NY/ | FTax withholding Common Stock | -426 | $33.82 | $14k | 7,900 | Apr 6, 2026 |
| Mar 31, 2025 | DCOM Dime Community Bancshares, Inc. /NY/ | AGrant or award Common Stock | +3,547 | $0.00 | $0 | 3,547 | Nov 18, 2025 |
Questions about Thomas X Geisel
Answered from the filings on this page, as of the latest one.
Is Thomas X Geisel buying or selling?
Thomas X Geisel has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Thomas X Geisel's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Thomas X Geisel has 0.
Where does Thomas X Geisel file Form 4?
Thomas X Geisel has filed Form 4 at DCOM (Dime Community Bancshares, Inc. /NY/) as SEVP& Chief Commercial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.